Interplay between proteostasis pathways and innate immune responses in <i>Caenorhabditis elegans</i>. [PDF]
Ghosh A, Singh J.
europepmc +1 more source
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, but their efficacy continues to be limited by immune‐related adverse events. Among these, ICI‐induced cardiac arrhythmias are increasingly recognised as a major adverse reaction, encompassing a broad spectrum of clinical phenotypes, including conduction blocks, atrial fibrillation and
Anand R. Ramalingam +3 more
wiley +1 more source
Loss of Proteostasis and Early-Onset Neurodegeneration in Down Syndrome: From Mechanisms to Interventions. [PDF]
Tramutola A +4 more
europepmc +1 more source
The lncRNA CROCCP2 upregulates HOXD11 by competitively adsorbing miR‐5584‐5p, thereby promoting glioma cell proliferation, migration, and invasion by inhibiting autophagy. It significantly enhances tumor growth in vivo, suggesting it may be a potential therapeutic target for gliomas.
Feng Wang +8 more
wiley +1 more source
Immune checkpoint blockade as an accelerator of adrenal aging: a testable model linking low-grade cortical inflammation to proteostasis failure, LDLR/SULT2A1 suppression, and reduced DHEA output. [PDF]
Ding G, Xu Y, Guo T, Feng C.
europepmc +1 more source
circMAN1A2 as an Isoform‐Resolved Circular RNA Hub in Cancer
circMAN1A2 as an isoform‐resolved circular RNA hub in cancer. circMAN1A2 is generated by back‐splicing of MAN1A2 pre‐mRNA, with alternative circularization producing multiple isoforms, including the predominant circMAN1A2(2–5). Its mechanistic interfaces include miRNA‐associated regulation, RBP binding/proteostasis control, BSJ‐mediated RNA–RNA pairing,
Hanyu Shang +4 more
wiley +1 more source
Diabetes, hipoxia e doenças cardiovasculares: do mecanismo molecular ao tratamento
João Vasco Ferreira
doaj +1 more source
Integrative genomic and functional analyses reveal NINL as a modulator of tau aggregation. [PDF]
Swift SK +14 more
europepmc +1 more source
A next-generation HDAC6 inhibitor for amyotrophic lateral sclerosis and frontotemporal dementia. [PDF]
James RE +16 more
europepmc +1 more source

